Shopping Cart
- Remove All
- Your shopping cart is currently empty
IACS-13909 (BBP-398), a specific and potent allosteric inhibitor of SHP2, that suppresses signaling through the MAPK pathway.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 91 € | In Stock | |
5 mg | 227 € | In Stock | |
10 mg | 359 € | In Stock | |
25 mg | 511 € | In Stock | |
50 mg | 723 € | In Stock | |
100 mg | 937 € | In Stock | |
1 mL x 10 mM (in DMSO) | 249 € | In Stock |
Description | IACS-13909 (BBP-398), a specific and potent allosteric inhibitor of SHP2, that suppresses signaling through the MAPK pathway. |
Targets&IC50 | SHP2:15.7 nM |
In vitro | IACS-13909 potently impeded proliferation of tumors harboring a broad spectrum of activated RTKs as the oncogenic driver. |
In vivo | In EGFR-mutant osimertinib-resistant NSCLC models with EGFR-dependent and EGFR-independent resistance mechanisms, IACS-13909, administered as a single agent or in combination with osimertinib, potently suppressed tumor cell proliferation?in vitro?and caused tumor regression?in vivo. |
Alias | BBP-398 |
Molecular Weight | 377.27 |
Formula | C17H18Cl2N6 |
Cas No. | 2160546-07-4 |
Smiles | CC1(N)CCN(CC1)c1cnc2c(n[nH]c2n1)-c1cccc(Cl)c1Cl |
Relative Density. | 1.402 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 9 mg/mL (23.86 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.